Author:
Riemann Burkhard,Schober Otmar
Publisher
Springer Berlin Heidelberg
Reference55 articles.
1. Abdel-Nabi H, Dörr RJ, Lamonica DM, et al (1998) Staging of primary colorectal carcinomas with fluorine-18 fluorode-oxyglucose whole-body PET: correlation with histopatho-logic and CT findings. Radiology 206: 755–60
2. Anderson CJ, Dehdashti F, Cutler PD, et al (2001) 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med 42: 213–21
3. Anderson CD, Rice MH, Pinson CW, et al (2004) Fluorode-oxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8: 90–7
4. Antoch G, Vogt FM, Veit P, et al (2005) Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med 46: 520–5
5. Arulampalam TH, Francis DL, Visvikis D, et al (2004) FDG-PET for the pre-operative evaluation of colorectal liver metastases. Eur J Surg Oncol 30: 286–91